Learn More
The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University(More)
The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines † Representing the European Association for Cardio-Thoracic Surgery (EACTS). Other ESC entities having participated in the development of this document:. The content of these European Society of Cardiology (ESC) Guidelines has been published for(More)
To identify loci affecting the electrocardiographic QT interval, a measure of cardiac repolarisation associated with risk of ventricular arrhythmias and sudden cardiac death, we conducted a meta-analysis of three genome-wide association studies (GWAS) including 3,558 subjects from the TwinsUK and BRIGHT cohorts in the UK and the DCCT/EDIC cohort from North(More)
Fundamental research into molecular mechanisms of atrial fibrillation (AF) and improved understanding of processes involved in the initiation and maintenance of AF have transformed the traditional approach to its management by targeting only the electrical aspects, usually with antiarrhythmic drugs and, recently, by ablation. The antiarrhythmic potential of(More)
It has been estimated that the prevalence of heart failure with a reduced ejection fraction exceeds 20 million patients worldwide— about 2% of the general population in the Western world—and that the annual incidence is. 2 million patients per year. 1 The mortality of heart failure exceeds that of many malignancies. Significant healthcare improvements have(More)
By 2050, atrial fibrillation (AF) will be present in 2% of the general population and in a far higher proportion of elderly patients. Currently, we are content with rate control and anticoagulation in elderly asymptomatic patients, whereas in younger patients with symptomatic recurrent AF, pulmonary vein isolation is the treatment of choice. However, in a(More)
Our studies deal with fully automatic measurement of heart rate variability (HRV) in short term electrocardiograms. Presently, all existing HRV analysis programs require user intervention for ectopic beat identification, especially of supraventricular ectopic beats (SVE). This makes the HRV measurement in large, e.g. epidemiological studies problematic. In(More)
Atrial fibrillation (AF) is generally considered a progressive disease, typically evolving from paroxysmal through persistent to 'permanent' forms, a process attributed to electrical and structural remodelling related to both the underlying disease and AF itself. Medical treatment has yet to demonstrate clinical efficacy in preventing progression. Large(More)
The project was funded by the U. S. Agency for International Development (USAID) under the terms of the FRONTIERS Program cooperative agreement number HRN-A-00-98-00012-00 and Population Council Subagreement number AI00.66A " Testing two models of postabortion family planning services to reduce repeat abortions in Russia. " The opinions expressed herein are(More)